NEDAPLATIN

作品数：18被引量：118H指数：5
导出分析报告
相关领域：医药卫生更多>>
相关作者：孙忠民崔一民周颖更多>>
相关机构：北京大学第一医院自治医科大学安徽省立医院更多>>
相关期刊：《World Journal of Clinical Cases》《Cancer Communications》《Journal of Hainan Medical University》《China Medical Abstracts(Internal Medicine)》更多>>
相关基金：安徽省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Effect of Endo Combined with Paclitaxel and Nedaplatin Concurrent Chemotherapy and Radiotherapy on Quality of Life of Patients with Non-small Cell Lung Cancer
《外文科技期刊数据库(文摘版)医药卫生》2022年第8期132-136,共5页ZHANShucai WANGXianyong 
Objective: to explore the effect of Endo combined with paclitaxel and nedaplatin on the quality of life of patients with non-small cell lung cancer. Methods: from January 2019 to December 2021, 32 patients with non-sm...
关键词：ENDO PACLITAXEL NEDAPLATIN non-small cell lung cancer quality of life 
Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
《World Journal of Clinical Cases》2022年第11期3414-3425,共12页Rui-Xue Huo Ying-Ying Jin Yong-Xue Zhuo Xiao-Tong Ji Yu Cui Xiao-Jing Wu Yi-Jia Wang Long Zhang Wen-Hua Zhang Yu-Mei Cai Cheng-Cheng Zheng Rui-Xue Cui Qian-Ye Wang Zhen Sun Feng-Wei Wang 
Supported by Tianjin Science and Technology Plan Project,No. 19YFZCSY00170;Tianjin Union Medical center,No. 2019YJ007;Beijing medical and health foundation,No. F1814B
BACKGROUND Patients with recurrent or locally advanced head and neck squamous cell carcinoma(HNSCC)typically have limited treatment options and poor prognosis.AIM To evaluate the efficacy and safety of two drugs with ...
关键词：CHEMORADIOTHERAPY GEMCITABINE NEDAPLATIN Head and neck cancer RECURRENT Locally advanced 
Nedaplatin-induced syndrome of inappropriate secretion of antidiuretic hormone:A case report and review of the literature被引量：1
《World Journal of Clinical Cases》2021年第23期6810-6815,共6页Lei Tian Li-Ya He Hong-Zhen Zhang 
BACKGROUND Syndrome of inappropriate secretion of antidiuretic hormone(SIADH)is relatively common in several cancers,such as small cell lung cancer.However,nedaplatin-induced SIADH is rare.We describe a case of SIADH ...
关键词：NEDAPLATIN Syndrome of inappropriate secretion of antidiuretic hormone HYPONATREMIA Fluid restriction Sodium supplementation Case report 
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma被引量：52
《Cancer Communications》2020年第12期711-720,共10页Bo Zhang Ling Qi Xi Wang Jianping Xu Yun Liu Lan Mu Xingyuan Wang Lidan Bai Jing Huang 
This study was supported by the Chinese Society of Clinical Oncology(CSCO)-Hengrui Oncology Research Fund(No.Y-HR2018-364)。
Background:Effective therapeutic options are limited for patients with advanced esophageal squamous cell carcinoma(ESCC).The incorporation of an immune checkpoint inhibitor and a molecular anti-angiogenic agent into t...
关键词：ANTI-ANGIOGENESIS apatinib camrelizumab CHEMOTHERAPY esophageal squamous cell carcinoma FIRST-LINE immunotherapy liposomal paclitaxel NEDAPLATIN objective response rate 
Evaluation of the tumor load and adverse reactions of nedaplatin combined with paclitaxel liposome and with paclitaxel treatment of advanced esophageal cancer
《Journal of Hainan Medical University》2017年第8期114-117,共4页Jun-Ying Liang Mao-Nan Yang 
Objective:To evaluate the tumor load and adverse reactions of nedaplatin combined with paclitaxel liposome and with paclitaxel treatment of advanced esophageal cancer.Methods:A total of 68 patients with advanced esoph...
关键词：Advanced esophageal cancer PACLITAXEL LIPOSOME PACLITAXEL TUMOR LOAD ADVERSE effects 
Curative efficacy of thalidomide in combination with nedaplatin in the treatment of non-small cell lung cancer
《China Medical Abstracts(Internal Medicine)》2016年第1期33-,共1页徐成 
Objective To investigate the curative efficacy of thalidomide in combination with nedaplatin in the treatmentof non-small cell lung cancer(NSCLC).Methods Totally 108 cases with NSCLC meeting the inclusion criteria fro...
关键词：THALIDOMIDE INCLUSION CURATIVE equally servation HEMOGLOBIN THALIDOMIDE statistically 
Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma被引量：23
《World Journal of Gastroenterology》2013年第48期9447-9452,共6页Ze-Tian Shen Xin-Hu Wu Bing Li Jun-Shu Shen Zhen Wang Jing Li Xi-Xu Zhu 
AIM:To evaluate the efficacy and toxicity of nedaplatin(NDP)concurrent with radiotherapy in the treatment of locally advanced esophageal carcinoma.METHODS:Sixty-eight patients with locally advanced esophageal carcinom...
关键词：ESOPHAGEAL carcinoma CHEMORADIOTHERAPY NEDAPLATIN CISPLATIN 
A phase Ⅱ study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma被引量：16
《World Journal of Gastroenterology》2013年第35期5910-5916,共7页Yi-Fu He Chu-Shu Ji Bing Hu Ping-Sheng Fan Chang-Lu Hu Feng-Shou Jiang Jian Chen Lei Zhu Yi-Wei Yao Wei Wang 
Supported by Natural Science Foundation of Anhui Province No.070413256X;Medical Research Foundation of Anhui Provincial Health Department No.2010B001 and No.13zc012
AIM:To evaluate the efficacy and safety of paclitaxelnedaplatin combination as a front-line regimen in Chinese patients with metastatic esophageal squamous cell carcinoma(ESCC).METHODS:A two-center,open-label,single-a...
关键词：Esophageal SQUAMOUS cell cancer FRONTLINE CHEMOTHERAPY PACLITAXEL NEDAPLATIN 
17 cases of advanced non-small cell lung cancer treated with paclitaxel liposome plus nedaplatin
《The Chinese-German Journal of Clinical Oncology》2012年第4期196-198,共3页Tao Suo Wei Ge Jinzhong Zhang Yongfa Zheng Shunxiang Luo 
Objective： The aim of this study was to evaluate the recent efficacy and adverse reactions of paclitaxel liposome plus nedaplatin in the treatment of advanced non-small cell lung cancer （NSCLC）. Methods： Seventeen...
关键词：paclitaxel liposome NEDAPLATIN non-small cell lung cancer （NSCLC） 
Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer: A Randomized Clinical Trial被引量：18
《Chinese Journal of Cancer Research》2012年第2期97-102,共6页Jin-ji Yang Qing Zhou Ri-qiang Liao Yi-sheng Huang Chong-rui Xu Zhen Wang Bin-chao Wang Hua-jun Chen Yi-long Wu 
Objective： To evaluate the efficacy and safety of nedaplatin/gemcitabine （NG） and carboplatin/gemcitabine （CG） in the management of untreated advanced non-small cell lung cancer （NSCLC）. Methods： Sixty-two pa...
关键词：Non-small cell lung cancer CHEMOTHERAPY NEDAPLATIN CARBOPLATIN GEMCITABINE Squamous cell carcinoma 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部